Verition Fund Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History
Bought
Maintained
Sold
Other funds holding AONC
CH
SCM
AIMCA
AA
UOC
GCL
FTCM
SCM
KIM
MSU
Verition Fund Management's AONC Position: Q1 2023 in Review
Verition Fund Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 94,866 shares — an estimated $953K sold.
Verition Fund Management first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $2.45M in Q2 2021. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.
- Verition Fund Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- Verition Fund Management sold 94,866 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $953K.
- Verition Fund Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
- Verition Fund Management's American Oncology Network, Inc. Class A Common Stock position peaked at $2.45M in Q2 2021.
- 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.